ThompsonAJBanwellBLBarkhofF, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17: 162–173.
2.
WingerchukDMBanwellBBennettJL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology2015; 85: 177–189.
3.
BanwellBBennettJLMarignierR, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol2023; 22(3): 268–282.
4.
ShinodaKMasakiKMatsuyoshiA, et al. Tumefactive demyelinating lesion during B cell depletion therapy by ofatumumab. Mult Scler J2025.
5.
SolomonAJArrambideGBrownleeWJ, et al. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. Lancet Neurol2023; 22: 750–768.
6.
MaillartEDurand-DubiefFLouapreC, et al. Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies. J Neuroinflammation2020; 17: 128.
7.
SaucierLRossorTGormanMP, et al. Diagnosis and management of children with atypical neuroinflammation. Neurology2025; 104: e213537.
